Nuechterlein Carole Insider Trades

Insider Trading History

Track insider trading activity for Nuechterlein Carole. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $30.8k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $316k 60,000 shares
Last Trade
Jun 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$568k 60,000 shares
$9.46
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $23.2k 4,411 shares
Last Trade
Feb 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 4,411 shares
$24.00
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $0 0 shares
Last Trade
Feb 27, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$356k 15,000 shares
$23.75
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
10% owner
Holding Value $58M 11,025,941 shares
Last Trade
Oct 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$183M 11,900,401 shares
$15.37
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $105k 20,000 shares
Last Trade
Jul 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 20,000 shares
$25.00
$5.26
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $78.9k 15,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$503k 15,000 shares
$33.50
$5.26
Entrada Therapeutics
Entrada Therapeutics TRDA
Director
Holding Value $83.4k 11,918 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.2k 11,918 shares
$6.06
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
Director
Holding Value $165k 23,522 shares
Last Trade
Oct 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$7.00
Aligos Therapeutics
Aligos Therapeutics ALGS
Director
Holding Value $78.9k 15,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.97M 15,000 shares
$664.50
$5.26
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $15.6k 12,000 shares
Last Trade
Jun 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$432k 12,000 shares
$36.00
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $12.7k 12,000 shares
Last Trade
Jun 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.8k 12,000 shares
$2.40
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $15.6k 12,000 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 12,000 shares
$173.85
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $12.7k 12,000 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 12,000 shares
$11.59
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $7.8k 6,000 shares
Last Trade
Jan 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$792k 6,000 shares
$132.00
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $6.36k 6,000 shares
Last Trade
Jan 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 6,000 shares
$8.80
$1.06
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $6.36k 6,000 shares
Last Trade
Jan 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 6,000 shares
$8.80
$1.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up